Stock screenerAll disclosures →
EDGAR →
RVMD
Conviction 100HealthcareScan · Thu, Jun 25, 2026RVMD$178.13+4.92%
ResistanceSupportVol 14Insider sell5
3
3
Vol MA14 3.17M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price178.13
Change+4.92%
Gap+0.67%
Rel volume2.58×
Avg volume3.44M
Avg $ vol550.36M
SMA 20157.70
SMA 50150.64
SMA 20097.80
Price vs 50+18.25%
Price vs 200+82.14%
MA stackbullish
50/200 cross—
Supertrendup · 154.82
RSI (14)71
MACD hist1.79
MACD crossbull · 4d
Stoch %K / %D86 / 92
ADX (14)33
+DI / −DI40 / 10
RSI divergence—
MACD divergence—
ATR %+3.92%
ADR %4.36%
52w high178.13
52w low34.70
From 52w high+0.00%
Above 52w low+413.34%
New 52w highYes
SqueezeOff
Bollinger width21.13%
%B1.11
Donchian pos86.01%
Donchian high184.10
Donchian low141.44
AVWAP (52w high)176.95
vs AVWAP high+0.67%
AVWAP (52w low)100.13
vs AVWAP low+77.89%
OBV trendUp
Chaikin MF (20)0.24
Today vs 20d2.58×
Avg vol (14d)3.17M
Avg vol (20d)3.44M
Avg $ vol (20d)550.36M
Market cap37.87B
RS 3m (vs SPY)+65.48%
RS 6m (vs SPY)+107.76%
RS line new highYes
Trend template8/8
Technical rank95.0
1 week+12.90%
1 month+15.00%
3 months+88.92%
6 months+121.06%
1 year+344.99%
YTD+125.42%
P/E-33.47
P/B25.25
P/S—
P/FCF-41.45
EPS-5.95
Div yield—
ROE-75.42%
ROA-50.20%
Debt/Eq—
Current6.80
EV/EBITDA-31.76
Gross margin—
Net margin—
Rev growth—
EPS growth-88.52%
Price target185.11
Target upside3.92%
Analyst ratingBuy
Institutional101.09%
Ent. value37.43B
Revenue0
Net income-453.82M
Gross profit—
Free cash flow-913.73M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out212.6M
Employees883
ListedThu, Feb 13, 2020
Free float152.8M
Float %79.0%
Short interest11.59M
Days to cover4.2d
Short volume40.6%
Squeeze score52 / 100
Next earningsWed, Aug 5, 2026 (41d)
EPS forecast−$1.90 · 9 est
Last EPS vs est−$2.29 vs −$1.83
Last surprise-25.1% miss
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank95.0 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance161.37
Support140.99
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in RVMD
No recent disclosed trades by Congress in RVMD. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in RVMD · 1 buy · 9 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Anders Jack Chief Financial Officer · Common Stock · 2026-06-16 | Sell | 2.72K | $425K | 2026-06-16 | 2026-06-18 |
Cislini Jeff General Counsel · Common Stock · 2026-06-16 | Sell | 2.16K | $337K | 2026-06-16 | 2026-06-18 |
Kelsey Stephen Michael See Remarks · Common Stock · 2026-06-16 | Sell | 4.17K | $652K | 2026-06-16 | 2026-06-18 |
Mancini Anthony See Remarks · Common Stock · 2026-06-16 | Sell | 4.62K | $720K | 2026-06-16 | 2026-06-18 |
GOLDSMITH MARK A See Remarks · Common Stock · 2026-06-16 | Sell | 10.02K | $1.6M | 2026-06-16 | 2026-06-18 |
Mancini Anthony See Remarks · Common Stock · 2026-05-26 | Sell | 2K | $308K | 2026-05-26 | 2026-05-28 |
Mancini Anthony See Remarks · Common Stock · 2026-05-26 | Sell | 421 | $65K | 2026-05-26 | 2026-05-28 |
Mancini Anthony See Remarks · Stock Option (Right to Buy) · 2026-05-26 | Exercise | 3.12K | $0 | 2026-05-26 | 2026-05-28 |
Mancini Anthony See Remarks · Common Stock · 2026-05-26 | Exercise | 3.12K | $105K | 2026-05-26 | 2026-05-28 |
Mancini Anthony See Remarks · Common Stock · 2026-05-26 | Sell | 700 | $107K | 2026-05-26 | 2026-05-28 |
SEC filings
EDGAR filings in RVMD · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.